- Home
- PDEX vs COEP Comparison
PDEX vs COEP Comparison
Compare PDEX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDEX | COEP |
|---|---|---|
| Founded | 1978 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 100.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PDEX | COEP |
|---|---|---|
| Price | $43.91 | $14.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $56.00 | N/A |
| AVG Volume (30 Days) | 29.7K | ★ 91.6K |
| Earning Date | 01-29-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.94 | N/A |
| EPS | ★ 3.31 | N/A |
| Revenue | ★ $70,231,000.00 | $500,996.00 |
| Revenue This Year | $7.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.09 | ★ N/A |
| Revenue Growth | ★ 23.65 | N/A |
| 52 Week Low | $23.47 | $2.31 |
| 52 Week High | $70.26 | $21.41 |
Technical Indicators
Market Signals| Indicator | PDEX | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 76.43 | 43.61 |
| Support Level | $39.72 | $14.82 |
| Resistance Level | $44.49 | $16.60 |
| Average True Range (ATR) | 1.85 | 1.43 |
| MACD | 0.62 | -0.24 |
| Stochastic Oscillator | 95.72 | 1.18 |
Price Performance
Historical ComparisonAbout PDEX Pro-Dex Inc.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.